Medirom Healthcare Technologies Inc. (MRM) Common Equity (2019 - 2025)
Medirom Healthcare Technologies (MRM) posted quarterly Common Equity of $2.1 million for Q2 2025, up 188.0% year-over-year from $715121.9 in Q2 2024, and down 68.31% quarter-over-quarter from $6.5 million in Q4 2024.
Medirom Healthcare Technologies Inc. (MRM) Common Equity (2019 - 2025) Analysis & Trends
Medirom Healthcare Technologies' Common Equity history runs 7 years deep, the most recent figure standing at $2.1 million for Q2 2025.
- In Q2 2025, Common Equity rose 188.0% year-over-year to $2.1 million; the TTM figure through Jun 2025 stood at $2.1 million (up 188.0% YoY), while the FY2024 annual figure was $6.5 million, up 321.72% from the prior year.
- Common Equity for Q2 2025 stood at $2.1 million, down from $6.5 million in the prior quarter.
- The five-year high for Common Equity was $6.5 million in Q4 2024, with the low at -$3.0 million in Q2 2023.
- The 5-year median for Common Equity is -$420296.4 (2022), against an average of $140986.1.
- The sharpest annual moves came in 2022 and 2023: Common Equity tumbled 260.15% in 2022, then surged 447.62% in 2023.
- Medirom Healthcare Technologies' Common Equity stood at -$1.8 million in 2021, then surged by 77.07% to -$420296.4 in 2022, then jumped by 447.62% to $1.5 million in 2023, then surged by 344.77% to $6.5 million in 2024, then sank by 68.31% to $2.1 million in 2025.
- Business Quant data shows MRM's Common Equity at $2.1 million in Q2 2025, $6.5 million in Q4 2024, and -$2.3 million in Q2 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.06 Mn |
| Dec 31, 2024 | 6.50 Mn |
| Jun 30, 2024 | -2.34 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Jun 30, 2023 | -3.02 Mn |
| Dec 31, 2022 | -420,296.40 |
| Jun 30, 2022 | -3.01 Mn |
| Dec 31, 2021 | -1.83 Mn |
| Jun 30, 2021 | 1.88 Mn |
| Dec 31, 2020 | 4.70 Mn |
| Dec 31, 2019 | 5.52 Mn |